KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,317,000 | -94.2% | 5,949 | -92.1% | 0.00% | – |
| Q2 2022 | $22,603,000 | +208.8% | 75,342 | +1320.5% | 0.00% | – |
| Q1 2022 | $7,320,000 | -98.6% | 5,304 | -98.8% | 0.00% | -100.0% |
| Q4 2021 | $539,540,000 | +1830.0% | 445,901 | +4079.0% | 0.00% | – |
| Q3 2021 | $27,955,000 | +130.4% | 10,670 | +366.1% | 0.00% | – |
| Q2 2021 | $12,132,000 | -65.1% | 2,289 | -55.6% | 0.00% | – |
| Q1 2021 | $34,785,000 | -46.6% | 5,161 | -46.3% | 0.00% | – |
| Q4 2020 | $65,115,000 | -14.5% | 9,604 | -5.4% | 0.00% | – |
| Q3 2020 | $76,162,000 | +327.0% | 10,155 | +498.4% | 0.00% | – |
| Q2 2020 | $17,835,000 | -75.6% | 1,697 | -79.6% | 0.00% | – |
| Q1 2020 | $73,071,000 | +381.2% | 8,313 | +102.0% | 0.00% | – |
| Q4 2019 | $15,184,000 | +36.2% | 4,115 | +40.5% | 0.00% | – |
| Q3 2019 | $11,145,000 | -6.3% | 2,929 | +57.1% | 0.00% | – |
| Q2 2019 | $11,899,000 | -57.8% | 1,865 | -45.3% | 0.00% | – |
| Q1 2019 | $28,201,000 | +1552.1% | 3,410 | +877.1% | 0.00% | – |
| Q4 2018 | $1,707,000 | -67.0% | 349 | -33.4% | 0.00% | – |
| Q3 2018 | $5,172,000 | -28.1% | 524 | 0.0% | 0.00% | – |
| Q2 2018 | $7,195,000 | -84.3% | 524 | -81.9% | 0.00% | – |
| Q1 2018 | $45,907,000 | +59.9% | 2,900 | +86.7% | 0.00% | – |
| Q4 2017 | $28,715,000 | +482.1% | 1,553 | +619.0% | 0.00% | – |
| Q3 2017 | $4,933,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,704,849 | $9,036,000 | 6.19% |
| RA Capital Management | 10,874,613 | $57,635,000 | 0.92% |
| Mesirow Financial Investment Management, Inc. | 42,104 | $223,000 | 0.57% |
| ACT CAPITAL MANAGEMENT, LLC | 190,000 | $1,007,000 | 0.52% |
| Samsara BioCapital, LLC | 601,162 | $3,186,000 | 0.39% |
| Orbimed Advisors | 5,465,030 | $28,965,000 | 0.29% |
| ALGERT GLOBAL LLC | 72,490 | $384,000 | 0.13% |
| Knights of Columbus Asset Advisors LLC | 236,257 | $1,252,000 | 0.12% |
| Bridgefront Capital, LLC | 47,569 | $252,000 | 0.10% |
| Matisse Capital | 56,100 | $297,000 | 0.09% |